Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

NOXXON Pharma N. V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia.

Similar securities

Based on sector and market capitalization

Report issue